Rapamycin PLGA Nanoparticles
| 【Numbering】BKNM-VN121 | 【CAS】53123-88-9 | ||
| 【Item No.】BKNM-VN121-03 | 【specification】 | ||
|
|||
Item No.: BKNM-VN121
Packing specification: 1ml / 5ml / 10ml
Particle size control: 100~140 nm
Average potential: ~ -20 mV
Polydispersity coefficient: ≤ 0.2
Basic application: immunosuppressive for scientific research
Main components: polymer material PLGA, PVA chemical agent (SIGMA)
Preparation method: homogenization method
Encapsulation factor: rapamycin
Storage conditions: 4℃ low temperature
Life cycle: 6-12 months
Sterilization method: filter sterilization
Message
Packing specification: 1ml / 5ml / 10ml
Particle size control: 100~140 nm
Average potential: ~ -20 mV
Polydispersity coefficient: ≤ 0.2
Basic application: immunosuppressive for scientific research
Main components: polymer material PLGA, PVA chemical agent (SIGMA)
Preparation method: homogenization method
Encapsulation factor: rapamycin
Storage conditions: 4℃ low temperature
Life cycle: 6-12 months
Sterilization method: filter sterilization
Usage: cell administration; animal intravenous injection
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： PE immunotoxin nanopar
